Millie
your market intelligence analyst
Search Results
382 results
Your search is now limited to «Partnerships and Collaborations» expert search.
Patients interested in participating in one of Lilly's clinical trials for a potential COVID-19 treatment should visit Lilly TrialGuide for information regarding eligibility for ongoing trials.
More from Healthcare Sales & Marketing Network:
3BL Media 07/29/2020 10:40
Gilead will initially provide $1 million to Satcher for the project and also to support the creation of a Black Health Equity Alliance, composed of national thought leaders, community representatives, scholars, researchers and policymakers, that will ...
More from 3BL Media:
GlobeNewswire 07/29/2020 09:00
Denali and Sanofi entered a broad partnership in October 2018 for the global development and commercialization of RIPK1 inhibitors.
More from GlobeNewswire:
STAT 07/29/2020 07:00
The pharmaceutical giant GlaxoSmithKline is starting human trials of the first medicine, a cancer drug, that has emerged from its two-year-old collaboration with consumer genetics firm 23andMe.
More from STAT:
Business Wire 07/28/2020 09:00
Gilead will initially provide $1 million for the project and also to support the creation of a Black Health Equity Alliance, composed of national thought leaders, community representatives, scholars, researchers and policymakers, which will help coordinate ...
More from Business Wire:
Bionity.com 07/28/2020 00:28
Profits shared with AstraZeneca from those countries will be recorded as Collaboration Revenue by AstraZeneca.
More from Bionity.com:
Investor's Business Daily 07/27/2020 12:51
This collaboration reflects AstraZeneca's strategy to invest in antibody drug conjugates as a class, the innovative nature of the technology and the successful existing collaboration with Daiichi Sankyo," AstraZeneca said in its press release.
More from Investor's Business Daily:
This new strategic collaboration with AstraZeneca, a company with extensive experience and significant expertise in the global oncology business, will enable us to deliver DS-1062 to more patients around the world as quickly as possible.
More from Genetic Engineering & Biotechnology News:
Pharmafile 07/27/2020 08:09
This new strategic collaboration with AstraZeneca, a company with extensive experience and significant expertise in the global oncology business, will enable us to deliver DS-1062 to more patients around the world as quickly as possible.
More from Pharmafile:
Benzinga 07/27/2020 05:58
What Happened The two companies have entered into a global development and commercialization agreement for Daiichi's antibody drug conjugate (ADC) DS-1062, a potential new medicine for the treatment of multiple tumor types, AstraZeneca noted.
More from Benzinga:
Homeland Preparedness News 07/22/2020 08:10
CureVac and GlaxoSmithKline plc (GSK) have signed an agreement to work together on the research, development, manufacturing, and marketing of as many as five mRNA-based vaccines and monoclonal antibodies for use against infectious diseases.
More from Homeland Preparedness News:
Roche pharma partnering head James Sabry said: “Partnering with biotech companies that have innovative approaches to drug discovery is an essential part of Roche’s research strategy.
More from Pharmaceutical Business Review:
PharmaTimes 07/22/2020 05:18
Roche and Jnana Therapeutics have entered into a collaboration to discover new medicines targeting key regulators of cellular metabolism to treat immune-mediated and neurological diseases.
More from PharmaTimes:
PharmTech.com 07/21/2020 12:00
GlaxoSmithKline (GSK) and CureVac announced in a July 20, 2020 press release that they have signed a strategic collaboration agreement for the research, development, manufacturing, and commercialization of up to five mRNA-based vaccines and monoclonal antibodies ...
More from PharmTech.com:
World Pharma News 07/21/2020 04:00
GSK and CureVac announce strategic mRNA technology collaboration.
More from World Pharma News:
BioPharma-Reporter 07/20/2020 10:04
Alongside the deal to collaborate on developing infectious disease targets, GSK will also make an equity investment of £130m (€150m), which sees the company take an approximate 10% stake in CureVac.
More from BioPharma-Reporter:
PR Newswire 07/15/2020 08:35
We are enthusiastic about the ability for biosimilars to help increase access to essential medicines and potentially lower the cost of care when utilized," said Andrew Coop , North America Medical Lead, Pfizer Oncology.
More from PR Newswire:
ENDPOINTS 07/15/2020 07:30
... why Glympse Bio was able to raise a $22 mil­lion Se­ries A two years ago off their NASH di­ag­no­sis plat­form and land a col­lab­o­ra­tion with Gilead, ar­guably the largest com­pa­ny mak­ing a ma­jor push in­to the field.
More from ENDPOINTS:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications